Monogram Biosciences Inc. (MGRM) is in the Pharma Industry

• Sort by

• Monogram Biosciences, Inc. Q4 2007 Earnings Call Transcript

  Monogram Biosciences, Inc. Q4 2007 Earnings Call Transcript

  Earnings calls 2008-02-18

  Tags: Monogram Biosciences Inc., Call Transcript, Earnings, Seeking Alpha, Financial Accounting, Finance

Additional Resources

• Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors

  PhenoSenseR Integrase Now Enables Clinicians to Monitor Activity of New Class of Potent Antiretroviral Drugs SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced the launch of its PhenoSenseR Integrase assay, built on Monogram's proprietary technology platform, PhenoSenseR. The assay directly measures...

  Articles 2008-08-04

• Monogram Announces 2008 Second Quarter Financial Results

  66% Revenue Growth; HERmark Breast Cancer Assay launched commercially - Conference call today at 4:30 p.m. ET - SOUTH SAN FRANCISCO, Calif., July 29 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today reported financial results for the quarter ended June 30, 2008. The Company...

  Articles 2008-07-29

• Monogram Announces Issuance of Key Patents Related to VeraTag™ Technology

  SOUTH SAN FRANCISCO, Calif., July 23 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. announced today that three key United States Patents for its proprietary VeraTagTM technology have been issued (United States Patent numbers 7,402,397; 7,402,398 and 7,402,399). The patents are broad and relate to the use of Monogram's VeraTag technology...

  Articles 2008-07-23

• Monogram Announces Commercial Availability of the HERmark™ Breast Cancer Assay

  Accurate and Quantitative Measurement of Breast Cancer Patient's HER2 Status Now Available to Physicians SOUTH SAN FRANCISCO, Calif., July 8 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced that, effective July 15, the HERmarkTM Breast Cancer Assay will be available to physicians throughout the...

  Articles 2008-07-08

• Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference

  SOUTH SAN FRANCISCO, Calif., July 1 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. announced today that William D. Young, CEO and Chairman, is scheduled to present an update on the company's business at the Collins Stewart LLC Fourth Annual Growth Conference on Tuesday, July 8, 2008 at...

  Articles 2008-07-01

• Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies

  PhenoSense GTTM and PhenoSense IntegraseTM assays used to study promising new Integrase inhibitor SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., announced today that the Company has signed an agreement with Gilead Sciences, Inc. to provide resistance testing and consultative...

  Articles 2008-06-18

• More than a Dozen Companion Diagnostic Tests are Approved for use in the United States and Guide the Prescription of Products in Oncology, Cardiovascular Disease and Infectious Diseases

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/441498/the_landscape_of_c) has announced the addition of Decision Resources, Inc.'s new report "The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends" to their offering. This report offers a comprehensive analysis of the companion diagnostics market: - the...

  Articles 2008-06-18

• Zacks Analyst Blog Highlights: Nortel Networks, Verizon, Shanghai Petrochemical, Monogram Biosciences and Pfizer

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Nortel Networks Corporation (NYSE: NT), Verizon (NYSE: VZ),...

  Articles 2008-06-17

• Sensitivity Enhancements to Monogram's Trofile™ Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy

  SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced that data related to the enhanced performance of the company's HIV tropism assay were presented in an oral presentation at the 17th International HIV Drug Resistance Workshop in Sitges, Spain. Trofile...

  Articles 2008-06-16

• Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile™ HIV Tropism Assay

  Now 100% Sensitive at Detecting CXCR4 HIV-1 Levels as Low as 0.3% SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced immediate availability of enhanced sensitivity in its Trofile assay. Trofile was introduced commercially upon FDA approval of SelzentryTM...

  Articles 2008-06-05

• Monogram Announces Presentation of Clinical Data for the HERmark™ Breast Cancer Assay at the 44th ASCO Annual Meeting

  Monogram announces availability of HERmark and HER1 and HER3 Total Protein Assays in Collaborative Biomarker Study SOUTH SAN FRANCISCO, Calif., June 2 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced that scientific collaborators have presented additional clinical results on HERmarkTM, the company's novel oncology assay, as a...

  Articles 2008-06-02

• Monogram Announces HERmark™ Oral Presentation at the 44th ASCO Annual Meeting

  Investigator to discuss assay built on VeraTagTM technology's ability to predict response to HerceptinR SOUTH SAN FRANCISCO, Calif., May 16 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. today announced that scientific collaborators will present results on HERmarkTM, the company's novel oncology assay, as a means to measure HER2...

  Articles 2008-05-16

• Before the Bell Report for Wednesday, April 2nd, 2008 - On the Radar: BDGR, BDRR, PUDC, ADVR, CCUR, MGRM.

  M2 PRESSWIRE-2 April 2008-The Micro Cap Opportunity: Before the Bell Report for Wednesday, April 2nd, 2008 - On the Radar: BDGR, BDRR, PUDC, ADVR, CCUR, MGRMC1994-2008 M2 COMMUNICATIONS LTD RDATE:02042008 LOS ANGELES - This morning's On the Radar' Micro Cap...

  Articles 2008-04-02

• Progressive Following on Monogram Biosciences, Inc.

  M2 PRESSWIRE-1 April 2008-Market Review: Progressive Following on Monogram Biosciences, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:01042008 Streetinvesting.com has now resumed our progressive review of Monogram Biosciences, Inc. (NASDAQ:MGRM) as it opened up $0.11 nearing its 52 week low of $1.01...

  Articles 2008-04-01

• Monogram Biosciences Inc. Review in Progress.

  M2 PRESSWIRE-31 March 2008-The Maybach Review: Monogram Biosciences Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:31032008 MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Investors wanting to know the truth about investing...

  Articles 2008-03-31

• Monogram Biosciences, Inc. Review in Progress.

  M2 PRESSWIRE-25 March 2008-Market Review: Monogram Biosciences, Inc. Review in ProgressC1994-2008 M2 COMMUNICATIONS LTD RDATE:26032008 Streetinvesting.com has now resumed our progressive review of Monogram Biosciences, Inc. (NASDAQ:MGRM) as it traded down more than 2% nearing its 52 week low...

  Articles 2008-03-25

• Breaking News Alert! Nacel Energy To Add 20 Mw Of New Capacity In Nations Premier Wind Energy Corridor.

  M2 PRESSWIRE-19 March 2008-SmallCapStockAlert.com: Breaking News Alert! Nacel Energy To Add 20 Mw Of New Capacity In Nations Premier Wind Energy CorridorC1994-2008 M2 COMMUNICATIONS LTD RDATE:19032008 Stocks to Watch: NACEL Energy Corporation (OTC BB:NCEN) , WATER CHEF INC (OTC...

  Articles 2008-03-19

• Breaking News Alert! (OTCBB:CGFI) Colorado Goldfields Inc. Purchases Underground Mining Equipment.

  M2 PRESSWIRE-18 March 2008-LiquidStockReport.com: Breaking News Alert! (OTCBB:CGFI) Colorado Goldfields Inc. Purchases Underground Mining EquipmentC1994-2008 M2 COMMUNICATIONS LTD RDATE:18032008 Stocks to Watch: Colorado Goldfields Inc. (OTCBB:CGFI) , INCA DESIGNS, INC. (PinkSheets: IDGI), BodyTel Scientific Inc. (OTC BB:BDYT) ,...

  Articles 2008-03-18

• Breaking Headlines from VIASPACE Inc. (OTCBB: VSPC).

  M2 PRESSWIRE-18 March 2008-GrowthStockResearch.com: Breaking Headlines from VIASPACE Inc. (OTCBB: VSPC)C1994-2008 M2 COMMUNICATIONS LTD RDATE:18032008 Stocks to Watch: VIASPACE Inc. (OTCBB: VSPC), Inspire Pharmaceuticals, Inc. (Nasdaq: ISPH), WATER CHEF INC (OTC BB: WTER), Monogram Biosciences, Inc. (Nasdaq: MGRM),...

  Articles 2008-03-18